Does Rallies show Form 4 insider transactions for KALV?

Yes. Rallies tracks KALV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is KALV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KALV. It does not provide personalized investment advice.

KALV (KalVista Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades

KalVista Pharmaceuticals, Inc. Common Stock (KALV) is a publicly traded Healthcare sector company. As of May 20, 2026, KALV trades at $26.77 with a market cap of $1.42B and a P/E ratio of -7.25. KALV moved +0.00% today. Year to date, KALV is +73.16%; over the trailing twelve months it is +121.79%. Its 52-week range spans $7.30 to $26.85. Analyst consensus is neutral with an average price target of $29.17. Rallies surfaces KALV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading KALV stock inside the company?

Recent KALV insider activity includes Palleiko Benjamin L sold 3.32K, Audhya Paul K. sold 2.69K, Sweeny Nicole sold 1.86K, Piekos Brian sold 1.86K, and Palleiko Benjamin L sold 9.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

KALV Key Metrics

Key financial metrics for KALV
Metric	Value
Price	$26.77
Market Cap	$1.42B
P/E Ratio	-7.25
EPS	$-3.69
Dividend Yield	0.00%
52-Week High	$26.85
52-Week Low	$7.30
Volume	7.34M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-183.44M
Gross Margin	0.00%

Recent KALV Insider Trades

Palleiko Benjamin L sold 3.32K (~$88.73K) on May 12, 2026.
Audhya Paul K. sold 2.69K (~$54.30K) on Apr 17, 2026.
Sweeny Nicole sold 1.86K (~$37.64K) on Apr 17, 2026.
Piekos Brian sold 1.86K (~$37.64K) on Apr 17, 2026.
Palleiko Benjamin L sold 9.55K (~$193.07K) on Apr 17, 2026.

Latest KALV News

Halper Sadeh Challenges KalVista’s $27 Cash Deal, Seeks Higher Consideration — May 19, 2026
Chiesi to Buy KalVista for $1.9B at 36% Premium — Apr 30, 2026
Chiesi Agrees $1.9B KalVista Deal at $27 Per Share as Citigroup Downgrades — Apr 29, 2026

KALV Analyst Consensus

8 analysts cover KALV: 0 strong buy, 2 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $29.17.

Common questions about KALV

Who is trading KALV stock inside the company?: Recent KALV insider activity includes Palleiko Benjamin L sold 3.32K, Audhya Paul K. sold 2.69K, Sweeny Nicole sold 1.86K, Piekos Brian sold 1.86K, and Palleiko Benjamin L sold 9.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for KALV?: Yes. Rallies tracks KALV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is KALV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KALV. It does not provide personalized investment advice.